Private EquityScreenerRefer

MARKET INSIGHTS

  • EventsNEWPrivate market milestones
  • NewsPrecize daily pulse
  • BlogsIn-depth articles and opinions

GUIDES

Explore Now
  • Unlisted SharesStep-by-step · KYC
  • BuyingStep-by-step · KYC
  • SellingExit in 24 - 48 hours
  • Pre-IPOReturns · risks · case studies
  • Tax GuideBudget 2026 changes
  1. Home
  2. Unlisted share news
  3. Philips & ACTREC (Tata Memorial Cancer Centre) – Partner to Strengthen …

Philips & ACTREC (Tata Memorial Cancer Centre) – Partner to Strengthen Early Cancer Detection in India

3 Mar 2026

Add as preferred source
Key Takeaways

Key Takeaway:
The Philips–ACTREC collaboration brings next-generation Spectral CT technology into India’s cancer care ecosystem, enabling faster and more precise diagnosis, potentially reducing repeat procedures by 36% and improving clinical decision-making for complex cancer cases.

Key Takeaway:
The Philips–ACTREC collaboration brings next-generation Spectral CT technology into India’s cancer care ecosystem, enabling faster and more precise diagnosis, potentially reducing repeat procedures by 36% and improving clinical decision-making for complex cancer cases.

philips limited unlisted shares

Philips India

0.18%

Expert Analysis

Expert Analysis:

  • Philips has partnered with the Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), a unit of Tata Memorial Centre, to strengthen early cancer detection capabilities in India through advanced imaging technology.

  • The collaboration introduces Philips Spectral CT 7500, an advanced imaging system that captures detailed spectral information during routine CT scans, enabling deeper disease characterisation from a single scan and supporting earlier and more confident diagnoses.

  • The technology allows full-body exams in about two seconds and research indicates it can lead to 36% fewer additional diagnostic procedures in complex cancer evaluations, reducing patient anxiety, radiation exposure, and delays in treatment.

  • The system is expected to support multiple specialties including oncology, cardiology, neurology, and emergency care, where faster and more accurate diagnostic insights can significantly improve treatment decisions and patient outcomes.

Publisher:Bio Spectrum India